SCHEMBL4252575

SCHEMBL4252575

N#Cc1cc(=O)c2cccc(NC(=O)c3ccc(OCCCCc4ccccc4)cc3)c2o1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYSLTR2 Q9NS75 12/20 0.68
CYSLTR1 Q9Y271 12/20 0.68
NR1H4 Q96RI1 2/20 0.66
ABCC4 O15439 1/20 0.66
ABCB11 O95342 1/20 0.66
PGR P06401 1/20 0.66
HTR1A P08908 1/20 0.66
AR P10275 1/20 0.66
CHRM1 P11229 1/20 0.66
DRD1 P21728 1/20 0.66
PTGS1 P23219 1/20 0.66
SLC6A2 P23975 1/20 0.66
PDE4A P27815 1/20 0.66
ADORA1 P30542 1/20 0.66
ADRA1A P35348 1/20 0.66
OPRM1 P35372 1/20 0.66
DRD3 P35462 1/20 0.66
SLC6A3 Q01959 1/20 0.66
GPR17 Q13304 1/20 0.66
GPR35 Q9HC97 5/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6962442 0.99 CYSLTR2 (0.67) CYSLTR2CYSLTR1NR1H4ABCC4ABCB11
SCHEMBL6958160 0.88 GPR35 (0.68) CYSLTR2CYSLTR1NR1H4ABCC4ABCB11
SCHEMBL6961112 0.87 CYSLTR2 (0.65) CYSLTR2CYSLTR1NR1H4ABCC4ABCB11
SCHEMBL6951840 0.87 CYSLTR2 (0.65) CYSLTR2CYSLTR1NR1H4ABCC4ABCB11
SCHEMBL6955563 0.87 GPR35 (0.73) CYSLTR2CYSLTR1NR1H4ABCC4ABCB11
SCHEMBL4250595 0.85 CYSLTR2 (0.68) CYSLTR2CYSLTR1NR1H4ABCC4ABCB11
SCHEMBL28891400 0.85 GPR35 (0.65) CYSLTR2CYSLTR1NR1H4ABCC4ABCB11
SCHEMBL6956923 0.85 GPR35 (0.61) CYSLTR2CYSLTR1GPR35
SCHEMBL4780354 0.85 CYSLTR2 (0.67) CYSLTR2CYSLTR1NR1H4ABCC4ABCB11
SCHEMBL4255927 0.85 GPR35 (0.69) CYSLTR2CYSLTR1NR1H4ABCC4ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0634409-B1 Process of producing 2-cyano-4-oxo-4H-benzopyran compounds SUMITOMO CHEMICAL CO (JP) 2000-04-26 EP claimed
US-5659051-A Process of producing 2-cyano-4-oxo-4H-benzopyran compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1997-08-19 US claimed
EP-0634409-A1 Process of producing 2-cyano-4-oxo-4H-benzopyran compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1995-01-18 EP claimed
EP-2105431-A1 Process for Producing Chromone Compound Sumitomo Chemical Company, Limited (JP) 2009-09-30 EP disclosed
EP-2105432-A1 Process for Producing Chromone Compound Sumitomo Chemical Company, Limited (JP) 2009-09-30 EP disclosed
EP-1867626-A2 Process for producing chromone compound Sumitomo Chemical Company, Limited (JP) 2007-12-19 EP disclosed
US-20060217565-A1 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-09-28 US disclosed
US-7094914-B2 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-08-22 US disclosed
US-20050085664-A1 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LMITED (JP) 2005-04-21 US disclosed
EP-1479667-A1 PROCESS FOR PRODUCING CHROMONE COMPOUND Sumitomo Chemical Company, Limited (JP) 2004-11-24 EP disclosed
EP-1380578-A1 PROCESS FOR PRODUCING NITRILE COMPOUND ONO PHARMACEUTICAL CO., LTD. (JP) 2004-01-14 EP disclosed
EP-0711762-B1 PROCESS FOR PRODUCING TETRAZOLE COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2003-08-06 EP disclosed
US-6277998-B1 REACTING 2-CYANO-4-OXO-4H-BENZOPYRAN COMPOUND WITH HYDROGEN SULFIDE AND THEN REACTING PROUDCT WITH ALKYL HALIDE; REACTING THE PRODUCT WITH HYDRAZINE OR ITS SALT AND THEN WITH NITROUS ACID COMPOUND TO OBTAIN TETRAZOLE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-08-21 US disclosed
US-6191289-B1 REACTING A 4-OXO-4H-BENZOPYRAN GROUP SUBSTITUTED WITH AMIDE OR A PHENYL GROUP IN ITS 2 POSITION IS REACTED WITH ANHYDROUS HYDRAZINE OR SALT IN PRESENCE OF CATALYST FOLLOWED BY REACTING WITH NITROUS ACID OR SALT TO FORM TETRAZOLE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-02-20 US disclosed
EP-0634409-B1 Process of producing 2-cyano-4-oxo-4H-benzopyran compounds SUMITOMO CHEMICAL CO (JP) 2000-04-26 EP disclosed
US-5659051-A Process of producing 2-cyano-4-oxo-4H-benzopyran compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1997-08-19 US disclosed
EP-0711762-A1 PROCESS FOR PRODUCING TETRAZOLE COMPOUND AND INTERMEDIATE THEREFOR SUMITOMO CHEMICAL COMPANY LIMITED (JP) 1996-05-15 EP disclosed
EP-0634409-A1 Process of producing 2-cyano-4-oxo-4H-benzopyran compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1995-01-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050085664-A1 Process for producing chromone compound ENY2, CDY1; CDY1B, CDYL CYSLTR2 3843/4885CYSLTR1 4183/4885NR1H4 478/4885
US-20060217565-A1 Process for producing chromone compound ENY2, CDY1; CDY1B, CDYL CYSLTR2 3843/4885CYSLTR1 4183/4885NR1H4 478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.